Patents by Inventor Vikash Reebye

Vikash Reebye has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stabilized saRNA Compositions and Methods of Use
    Publication number: 20240018519
    Abstract: The invention relates to modified oligonucleotides, e.g., saRNAs useful in upregulating the expression of a target gene and therapeutic compositions comprising such oligonucleotides. Methods of using the oligonucleotides and the therapeutic compositions are also provided.
    Type: Application
    Filed: April 12, 2023
    Publication date: January 18, 2024
    Applicant: MiNA Therapeutics Limited
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Vikash Reebye
  • SIRT1-saRNA Compositions and Methods of Use
    Publication number: 20240002850
    Abstract: The invention relates to a saRNAs useful in upregulating the expression of the SIRT1 gene and therapeutic compositions comprising the saRNA. Methods of using the saRNA and the therapeutic compositions are also provided.
    Type: Application
    Filed: December 21, 2022
    Publication date: January 4, 2024
    Applicant: MiNA Therapeutics Limited
    Inventors: Siv Anita Hegre, Pinelopi Andrikakou, Vikash Reebye
  • STABILIZED HNF4A SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20230031703
    Abstract: The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: August 10, 2022
    Publication date: February 2, 2023
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Vikash Reebye
  • SIRT1-saRNA compositions and methods of use
    Patent number: 11566246
    Abstract: The invention relates to a saRNAs useful in upregulating the expression of the SIRT1 gene and therapeutic compositions comprising the saRNA. Methods of using the saRNA and the therapeutic compositions are also provided.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: January 31, 2023
    Assignee: MiNA Therapeutics Limited
    Inventors: Siv Anita Hegre, Pinelopi Andrikakou, Vikash Reebye
  • Stabilized HNF4A saRNA compositions and methods of use
    Patent number: 11447773
    Abstract: The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: September 20, 2022
    Assignee: MINA THERAPEUTICS LIMITED
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Vikash Reebye
  • COMPOSITIONS AND METHODS OF USING C/EBP ALPHA SARNA
    Publication number: 20220267770
    Abstract: The disclosure relates to a pharmaceutical composition comprising an saRNA targeting C/EBP? and at least one additional active agent. Methods of using the pharmaceutical composition are also provided.
    Type: Application
    Filed: July 27, 2020
    Publication date: August 25, 2022
    Inventors: Dmitry Gabrilovich, Robert Habib, Vikash Reebye
  • SIRT1-SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20220211740
    Abstract: The disclosure relates to a saRNAs useful in upregulating the expression of the SIRT1 gene and therapeutic compositions comprising the saRNA. Methods of using the saRNA and the therapeutic compositions are also provided.
    Type: Application
    Filed: April 9, 2020
    Publication date: July 7, 2022
    Inventors: Pinelopi Andrikakou, Alexandre Debacker, Vikash Reebye
  • COMBINATION THERAPIES COMPRISING C/EBP ALPHA SARNA
    Publication number: 20210254069
    Abstract: The invention relates to a combination therapy comprising an saRNA targeting C/EBP? and at least one additional active agent. Methods of using the combination therapy are also provided.
    Type: Application
    Filed: June 14, 2019
    Publication date: August 19, 2021
    Inventors: Helen L Lightfoot, Vikash Reebye, Pål Sætrom, David Blakey, Choon Ping Tan
  • SIRT1-SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20210102204
    Abstract: The invention relates to a saRNAs useful in upregulating the expression of the SIRT1 gene and therapeutic compositions comprising the saRNA. Methods of using the saRNA and the therapeutic compositions are also provided.
    Type: Application
    Filed: April 12, 2019
    Publication date: April 8, 2021
    Inventors: Siv Anita Hegre, Pinelopi Andrikakou, Vikash Reebye
  • C/EBP ALPHA SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20210024928
    Abstract: The invention relates to saRNA targeting a C/EBP? transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: February 15, 2019
    Publication date: January 28, 2021
    Inventors: Vikash Reebye, David Blakey
  • STABILIZED HNF4A SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20200255827
    Abstract: The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: September 7, 2018
    Publication date: August 13, 2020
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Vikash Reebye
  • STABILIZED SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20200208152
    Abstract: The invention relates to modified oligonucleotides, e.g., saRNAs useful in upregulating the expression of a target gene and therapeutic compositions comprising such oligonucleotides. Methods of using the oligonucleotides and the therapeutic compositions are also provided.
    Type: Application
    Filed: September 7, 2018
    Publication date: July 2, 2020
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Vikash Reebye